Evaluation of Propofol Dosing Based on Total Body Weight Using Closes-loop Anaesthesia Delivery System
NCT05305313 · Status: RECRUITING · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 46
Last updated 2026-04-27
Summary
The pharmacokinetic profile of various drugs is altered in obese patients especially those administered by the intravenous route. Propofol is the commonly used intravenous anesthetic agent for induction and maintenance of anaesthesia as part of total intravenous anaesthesia (TIVA) regimen. A major concern with propofol dosing based on total body weight (TBW) in obese patients is disproportionate drug administration leading to undue drug accumulation in body with a potential to overdosing, delayed recovery from anaesthesia, and adverse hemodynamic outcome. Studies on propofol dosing based on various weight scalars have recommended that lean body weight (LBW) should be used for calculating bolus dose during anaesthesia induction and TBW or adjusted body weight (ABW) for arriving at an infusion dose required for maintenance of anesthesia. Although propofol delivery based on dose calculated by TBW has been well researched the evidence for propofol delivery based on dose calculated by ABW is lacking.
Recent advance in the delivery of propofol has been the development of computer controlled anaesthesia delivery systems. These devices deliver propofol based on patient's frontal cortex electrical activity as determined by bispectral index (BIS). Evaluation of anaesthesia delivery by these systems has shown that they deliver propofol and maintain depth of anaesthesia with far more precision as compared to manual administration. One such indigenously developed computer controlled anaesthesia delivery system is the closed loop anesthesia delivery system (CLADS). CLADS functions on control of processed EEG response parameter captured from anesthetized patients with the help of a BIS- monitor, which is continuously fed into an automated drug infusion pump. The infusion pump then accordingly delivers the anesthetic drug to the patients based on pharmacodynamic requirements. The investigators plan to evaluate the propofol maintenance dose requirement based on TBW versus ABW using CLADS for propofol delivery.
Conditions
- Obesity, Morbid
- Anesthesia
- Propofol
Interventions
- DRUG
-
Propofol
Propofol delivery will be controlled using automated closed loop anaesthesia delivery system which will control propofol delivery rate to consistent anaesthetic depth (BIS-50) feedback from the patient.
- DRUG
-
Propofol
Propofol delivery will be controlled using automated closed loop anaesthesia delivery system which will control propofol delivery rate to consistent anaesthetic depth (BIS-50) feedback from the patient.
Sponsors & Collaborators
-
Sir Ganga Ram Hospital
lead OTHER
Principal Investigators
-
Goverdhan D Puri, MD, PhD · Post Graduate Institute of Medical Education & Research, Chandigarh, India
-
Jayashree Sood, MD, FFRCA, PGDHHM, FICA · Sir Ganga Ram Hospital, New Delhi, INDIA
Study Design
- Allocation
- RANDOMIZED
- Purpose
- BASIC_SCIENCE
- Masking
- DOUBLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2022-04-19
- Primary Completion
- 2027-11-04
- Completion
- 2027-11-10
Countries
- India
Study Locations
More Related Trials
-
Influence of Obesity on Propofol Pharmacokinetics During Cardiopulmonary Bypass
NCT02477982 ·Status: COMPLETED
-
Propofol Induction Based on Lean Body Weight on the Depth of Anesthesia
NCT06862349 ·Status: COMPLETED ·Phase: PHASE4
-
Development of PK/PD Model for Individualized Propofol Dosing
NCT00948597 ·Status: COMPLETED
-
The Effect of Propofol Induction Based on Lean Body Weight on the Depth of Anesthesia
NCT06862245 ·Status: COMPLETED ·Phase: NA
-
Quality Assessment of Orotracheal Intubation Without Neuromuscular Blocking Agents in Obese Patients
NCT05026125 ·Status: COMPLETED ·Phase: PHASE4
-
Balanced Propofol Sedation During Upper Endoscopy in Morbidly Obese Patients
NCT00782873 ·Status: COMPLETED
-
Automated Closed Loop Propofol Anaesthesia Versus Desflurane Inhalation Anaesthesia In Bariatric Surgery
NCT03099616 ·Status: COMPLETED ·Phase: PHASE4
-
Performance Analysis of Hermetic Closed-loop Anesthesia Delivery System
NCT05967403 ·Status: RECRUITING ·Phase: NA
-
Propofol Pharmacokinetics and Pharmacodynamics Modelling
NCT02713698 ·Status: COMPLETED
-
Population PK/PD of Propofol in the Morbidly Obese Patient
NCT00395681 ·Status: COMPLETED ·Phase: PHASE4
-
Effect of Gender on Propofol Requirement
NCT05725135 ·Status: COMPLETED
-
Comparison of Different Propofol Formulations
NCT01041872 ·Status: COMPLETED ·Phase: PHASE4
-
Comparison of Different Propofol Formulations With or Without Remifentanil
NCT01592162 ·Status: COMPLETED ·Phase: PHASE4
-
Comparison of TIVA by Closed Loop Anaesthesia Delivery System Versus Target Controlled Infusion Device
NCT04731480 ·Status: COMPLETED ·Phase: NA
-
Propofol Effect-Site Target Controlled Infusion in the Obese: Characterization of the Time Profile of Bispectral Index Response
NCT01665079 ·Status: COMPLETED ·Phase: PHASE4
-
Propofol in Obese Children
NCT01242241 ·Status: COMPLETED ·Phase: PHASE3
-
Sevoflurane Versus Intravenous Anaesthetic Agents in Morbid Obese Patients
NCT01279499 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Behaviour of Intravenous Solutions in Obese Patients Under General Anesthesia
NCT01652131 ·Status: UNKNOWN ·Phase: NA
-
Blood Propofol Measurement During Anaesthesia Using Propofol Target Controlled Infusion
NCT01549639 ·Status: COMPLETED
-
Opioid-based Versus Lidocaine-based Induction of Anesthesia With Propofol in Elderly
NCT05051007 ·Status: UNKNOWN ·Phase: PHASE4
-
Application of the Propofol Precise Infusion Model
NCT05158426 ·Status: COMPLETED
-
Effect of Subanaesthetic Dose of Ketamine on Depth of Anaesthesia Consistency
NCT06986109 ·Status: RECRUITING ·Phase: NA
-
Clinical Observation of Titration Induction and Convention Induction of Propofol
NCT02199522 ·Status: COMPLETED ·Phase: NA
-
Minimal Effective Concentration of Lidocaine in Propofol Lidocaine Mixture for Relief of Pain on Propofol Injection
NCT05165303 ·Status: UNKNOWN ·Phase: PHASE4
-
Population Pharmacokinetics and Clinical Individual Dosage Regimen of Propofoll Injection
NCT03422315 ·Status: UNKNOWN ·Phase: NA